撤回声明：KIF20B促进细胞增殖，可能是胰腺癌的潜在治疗靶点。
RETRACTION: KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.
作者信息
Oncology Journal Of
出版信息
J Oncol. 2025 May 6;2025:9869050. doi: 10.1155/jo/9869050. eCollection 2025.
Abstract
[This retracts the article DOI: 10.1155/2021/5572402.].
摘要
[本文撤回文章DOI: 10.1155/2021/5572402。]
相似文献
1
RETRACTION: KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.撤回声明：KIF20B促进细胞增殖，可能是胰腺癌的潜在治疗靶点。
J Oncol. 2025 May 6;2025:9869050. doi: 10.1155/jo/9869050. eCollection 2025.
2
KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.驱动蛋白家族成员20B（KIF20B）促进细胞增殖，可能是胰腺癌的潜在治疗靶点。
J Oncol. 2021 Sep 9;2021:5572402. doi: 10.1155/2021/5572402. eCollection 2021.
3
KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.KIF20B通过刺激细胞增殖促进透明细胞肾细胞癌的进展。
J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
4
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.鉴定 KIF20B 为乳腺癌的新型预后生物标志物和治疗靶点。
Int J Oncol. 2024 Apr;64(4). doi: 10.3892/ijo.2024.5631. Epub 2024 Mar 1.
5
KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.KIF20B和MET作为DIAPHs的核心基因，预示着预后不良并促进胰腺癌进展。
Pathol Res Pract. 2024 Feb;254:155046. doi: 10.1016/j.prp.2023.155046. Epub 2023 Dec 21.
6
Retraction.撤回。
Open Biomed Eng J. 2018 Sep 11;12:91. doi: 10.2174/1874120701812010091. eCollection 2018.
7
Retraction.撤回。
Dose Response. 2024 Oct 18;22(4):15593258241282445. doi: 10.1177/15593258241282445. eCollection 2024 Oct-Dec.
8
Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation.驱动蛋白家族成员 20B 通过促进细胞增殖来调节舌癌的进展。
Mol Med Rep. 2019 Mar;19(3):2202-2210. doi: 10.3892/mmr.2019.9851. Epub 2019 Jan 11.
9
Inhibition of miR-325 inhibits KIF20B expression and the colorectal cancer cells' invasion & proliferation.抑制miR-325可抑制KIF20B的表达以及结肠癌细胞的侵袭和增殖。
BMC Cancer. 2025 Apr 14;25(1):680. doi: 10.1186/s12885-025-13759-z.
10
Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer.伪足相关蛋白 KIF20B 通过伪足状肌动蛋白动态促进Gli1 诱导的人结直肠癌细胞上皮-间充质转化。
Mol Carcinog. 2018 Jul;57(7):911-925. doi: 10.1002/mc.22812. Epub 2018 Apr 10.
本文引用的文献
1
KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.驱动蛋白家族成员20B（KIF20B）促进细胞增殖，可能是胰腺癌的潜在治疗靶点。
J Oncol. 2021 Sep 9;2021:5572402. doi: 10.1155/2021/5572402. eCollection 2021.
2
KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target.KIF23增强胰腺导管腺癌的细胞增殖，是一个有效的治疗靶点。
Ann Transl Med. 2020 Nov;8(21):1394. doi: 10.21037/atm-20-1970.
3
ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer.ASPM 预测膀胱癌预后不良，并调节细胞增殖。
Kaohsiung J Med Sci. 2020 Dec;36(12):1021-1029. doi: 10.1002/kjm2.12284. Epub 2020 Aug 6.
4
AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.AK4 通过促进细胞增殖和侵袭促进 HER2 阳性乳腺癌的进展。
Dis Markers. 2019 Nov 20;2019:8186091. doi: 10.1155/2019/8186091. eCollection 2019.
5
KIF5A Promotes Bladder Cancer Proliferation and .KIF5A 促进膀胱癌增殖和.
Dis Markers. 2019 Jul 3;2019:4824902. doi: 10.1155/2019/4824902. eCollection 2019.
6
KIF3B Promotes the Proliferation of Pancreatic Cancer.KIF3B 促进胰腺癌的增殖。
Cancer Biother Radiopharm. 2019 Aug;34(6):355-361. doi: 10.1089/cbr.2018.2716. Epub 2019 Jun 3.
7
KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.KIF20B通过刺激细胞增殖促进透明细胞肾细胞癌的进展。
J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
8
Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.神经降压素-1/核蛋白结合蛋白-2 是一种强有力的预后标志物，并增强膀胱癌中的细胞增殖、迁移和侵袭。
Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018.
Zotero 插件